What to Know About One Maze Insider's $3 Million Stock Sale as Shares Surge 150% [Yahoo! Finance]
Maze Therapeutics, Inc. (MAZE)
Company Research
Source: Yahoo! Finance
As such, the shares originated from option exercises that were fully vested and immediately liquidated. The transaction was conducted entirely through direct holdings; no indirect entities participated. These 10 stocks could mint the next wave of millionaires › Atul Dandekar, chief strategy and business officer of Maze Therapeutics (NASDAQ:MAZE) , executed an option exercise and immediate sale of 72,500 shares for a total consideration of approximately $2.94 million, as disclosed in a recent SEC Form 4 filing Metric Value Shares sold (direct) Transaction value $2.94 million Post-transaction shares (direct) Post-transaction value (direct ownership) The transaction value is based on the SEC Form 4 weighted average purchase price ($40.56), and the post-transaction value based on the Dec. 30 market close ($40.56). What is the significance of this sale relative to Dandekar's total direct holdings? This transaction involved the net sale of 87.35% of Dandekar's dir
Show less
Read more
Impact Snapshot
Event Time:
MAZE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MAZE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MAZE alerts
High impacting Maze Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
MAZE
News
- Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- We Think Maze Therapeutics (NASDAQ:MAZE) Can Easily Afford To Drive Business Growth [Yahoo! Finance]Yahoo! Finance
- Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at Guggenheim.MarketBeat
- Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.MarketBeat
MAZE
Earnings
- 11/6/25 - Beat
MAZE
Sec Filings
- 1/9/26 - Form 4
- 1/8/26 - Form 4
- 1/7/26 - Form 144
- MAZE's page on the SEC website